Prosecution Insights
Prosecution Insights
39 pending office actions • 26 art units • 38 examiners • 0 of 39 (0%) have an AI response strategy ready • 24 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 17 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 17 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (10%) |
| §103 only | 12 (31%) |
| §102 only | 1 (3%) |
| §112 only | 3 (8%) |
| Double-patenting only | 2 (5%) |
| Double-patenting + other | 4 (10%) |
| Multi-statute (no §101) | 13 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAUSCH, SARAE L | 2 | 29.6% | +44.2% |
| WESTON, ALYSSA G | 1 | 60.0% | +51.3% |
| HABTE, KAHSAY | 1 | 85.0% | +7.4% |
| ABUZEINEH, HANAN ISAM | 1 | 56.0% | +51.4% |
| VALENCIA, JUAN C | 1 | 86.6% | +7.6% |
| POLIAKOVA-GEORGAN, EKATERINA | 1 | 64.0% | +17.9% |
| NICKOL, GARY B | 1 | 45.3% | +28.7% |
| BURKHART, MICHAEL D | 1 | 62.2% | +11.5% |
| TRAN, CHRISTINA L | 1 | 48.2% | +45.5% |
| BUI PHO, PASCAL M | 1 | 63.9% | -19.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18683412 | PRODRUGS FOR USE IN THE TREATMENT OF TISSUE DAMAGE | HABTE, KAHSAY | — |
| 18558770 | THERMOCHEMICAL REACTOR AND PROCESS | VALENCIA, JUAN C | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18009320 | CHIMERIC ANTIGEN RECEPTOR CELL | VIVLEMORE, TRACY ANN | 86d overdue |
| 18194235 | ELECTROCARDIOGRAPHIC IMAGING SYSTEM AND METHOD | BROWN, HELENE CATHERINE | 28d overdue |
| 18349406 | APPARATUSES AND METHODS FOR USE IN ULTRASOUND OPTICAL IMAGING | KELLOGG, MICHAEL S | 15d overdue |
| 17928457 | SYNTHESIS OF NANOPARTICLES | SPEER, JOSHUA MAXWELL | 8d |
| 17793221 | DRUG ELUTING BIOMATERIALS | PRAGANI, RAJAN | 12d |
| 17309348 | DIFFERENTIAL METHYLATION | BAUSCH, SARAE L | 22d |
| 18009936 | METHODS FOR DETECTING AND PREDICTING BREAST CANCER | BAUSCH, SARAE L | 27d |
| 18559778 | SYNTHETIC RECEPTORS | ABUZEINEH, HANAN ISAM | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18282061 | GENE THERAPY COMPOSITION AND TREATMENT OF RIGHT VENTRICULAR ARRHYTHMOGENIC CARDIOMYOPATHY | BURKHART, MICHAEL D | 3d overdue |
| 17309348 | DIFFERENTIAL METHYLATION | BAUSCH, SARAE L | 22d |
| 18009936 | METHODS FOR DETECTING AND PREDICTING BREAST CANCER | BAUSCH, SARAE L | 27d |
| 18792799 | METHOD FOR ENHANCING THE SUPPRESSIVE PROPERTIES OF TREG CELLS | WESTON, ALYSSA G | — |
| 18559778 | SYNTHETIC RECEPTORS | ABUZEINEH, HANAN ISAM | — |
| 18554454 | CASRX/CAS13D SYSTEMS TARGETING C9ORF72 | POLIAKOVA-GEORGAN, EKATERINA | — |
| 18550739 | CD160 Binding Domain | NICKOL, GARY B | — |
| 18277023 | GENE THERAPY FOR DOPAMINE TRANSPORTER DEFICIENCY SYNDROME | TRAN, CHRISTINA L | — |
| Art Unit | Apps |
|---|---|
| 1637 | 3 |
| 1632 | 3 |
| 1633 | 2 |
| 1643 | 2 |
| 1638 | 2 |
| 3798 | 2 |
| 3797 | 2 |
| 1736 | 2 |
| 1699 | 2 |
| 1631 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18792799 | METHOD FOR ENHANCING THE SUPPRESSIVE PROPERTIES OF TREG CELLS | WESTON, ALYSSA G | — | DP | Non-Final OA | — | Pending | Aug 02, 2024 |
| 18683412 | PRODRUGS FOR USE IN THE TREATMENT OF TISSUE DAMAGE | HABTE, KAHSAY | 1624 | §112Other | Non-Final OA | — | Pending | Feb 13, 2024 |
| 18559778 | SYNTHETIC RECEPTORS | ABUZEINEH, HANAN ISAM | 1633 | §102§103§112 | Non-Final OA | — | Pending | Nov 08, 2023 |
| 18558770 | THERMOCHEMICAL REACTOR AND PROCESS | VALENCIA, JUAN C | 1771 | §103 | Non-Final OA | — | Pending | Nov 03, 2023 |
| 18554454 | CASRX/CAS13D SYSTEMS TARGETING C9ORF72 | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §101§103§112 | Non-Final OA | — | Pending | Oct 06, 2023 |
| 18550739 | CD160 Binding Domain | NICKOL, GARY B | 1643 | §112 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18282061 | GENE THERAPY COMPOSITION AND TREATMENT OF RIGHT VENTRICULAR ARRHYTHMOGENIC CARDIOMYOPATHY | BURKHART, MICHAEL D | 1638 | §103Other | Final Rejection | 3d overdue | Pending | Sep 14, 2023 |
| 18277023 | GENE THERAPY FOR DOPAMINE TRANSPORTER DEFICIENCY SYNDROME | TRAN, CHRISTINA L | 1637 | §101§102§103§112 | Non-Final OA | — | Pending | Aug 11, 2023 |
| 18261411 | SUBJECT POSITIONING | BUI PHO, PASCAL M | 3798 | §103 | Final Rejection | — | Pending | Jul 13, 2023 |
| 18349406 | APPARATUSES AND METHODS FOR USE IN ULTRASOUND OPTICAL IMAGING | KELLOGG, MICHAEL S | 3798 | §103§112 | Non-Final OA | 15d overdue | Pending | Jul 10, 2023 |
| 18258414 | A SYSTEM FOR POSITIONING A MEDICAL TOOL | ASGHAR, AMINAH | 3797 | §103 | Final Rejection | 86d overdue | Pending | Jun 20, 2023 |
| 17910686 | GENE THERAPY OF NIEMANN-PICK DISEASE TYPE C | ABBOTT, KODYE LEE | 1634 | §103§112 | Non-Final OA | — | Pending | Jun 16, 2023 |
| 18267835 | POLYPEPTIDE | XIAO, YAN | 1642 | §102§103§112 | Non-Final OA | — | Pending | Jun 16, 2023 |
| 17915043 | ACTIVITY-DEPENDENT GENE THERAPY FOR NEUROLOGICAL DISORDERS | GROOMS, TIFFANY NICOLE | 1637 | §102§103§112DP | Non-Final OA | — | Pending | May 22, 2023 |
| 18194235 | ELECTROCARDIOGRAPHIC IMAGING SYSTEM AND METHOD | BROWN, HELENE CATHERINE | 3797 | §103§112 | Final Rejection | 28d overdue | Pending | Mar 31, 2023 |
| 18246447 | NUCLEIC ACID NANOSTRUCTURES FOR DELIVERY OF NUCLEIC ACID SEQUENCES TO CELLS | POPA, ILEANA | 1633 | §103 | Final Rejection | — | Pending | Mar 23, 2023 |
| 18042899 | PRODUCTION OF INORGANIC SALTS | ZIMMER, ANTHONY J | 1736 | §103 | Final Rejection | 44d overdue | Pending | Feb 24, 2023 |
| 18005577 | PIEZOELECTRIC AND PIEZOCATALYTIC COMPOSITE MATERIAL, AND METHODS OF USING AND FORMING IT | BREWSTER, HAYDEN R | 1779 | §103 | Non-Final OA | 49d overdue | Pending | Jan 13, 2023 |
| 18011583 | THERAPEUTICS FOR THE TREATMENT OF FSHD | SAMSELL, RILLA MARIE | 1626 | §102§112DP | Non-Final OA | — | Pending | Dec 20, 2022 |
| 18009945 | METHODS FOR DETECTING AND PREDICTING CANCER AND/OR CIN3 | KENNEDY, SARAH JANE | 1682 | DP | Final Rejection | 72d overdue | Pending | Dec 12, 2022 |
| 18009936 | METHODS FOR DETECTING AND PREDICTING BREAST CANCER | BAUSCH, SARAE L | 1699 | §101§102§112 | Non-Final OA | 27d | Pending | Dec 12, 2022 |
| 18009320 | CHIMERIC ANTIGEN RECEPTOR CELL | VIVLEMORE, TRACY ANN | 1638 | §103§112 | Non-Final OA | 86d overdue | Pending | Dec 08, 2022 |
| 17928457 | SYNTHESIS OF NANOPARTICLES | SPEER, JOSHUA MAXWELL | 1736 | §102§103 | Final Rejection | 8d | Pending | Nov 29, 2022 |
| 17998595 | CYCLOSPORINE ANALOGUES | BEANE, RANDALL L | 1654 | §102§112DP | Final Rejection | — | Pending | Nov 11, 2022 |
| 18047199 | GENE THERAPY FOR BARDET-BIEDL SYNDROME | MONTANARI, DAVID A | 1632 | §102§103 | Non-Final OA | — | Pending | Oct 17, 2022 |
| 17904388 | AGENTS FOR USE IN THE TREATMENT OF TISSUE DAMAGE | MCMILLIAN, KARA RENITA | 1623 | §102§112Other | Non-Final OA | — | Pending | Aug 17, 2022 |
| 17819757 | END-EFFECTOR FOR ENDOSCOPIC SURGICAL INSTRUMENT | MULLINS, JESSICA LYNN | 3792 | §102§103 | Non-Final OA | — | Pending | Aug 15, 2022 |
| 17798796 | GENE THERAPY | SINGH, ANOOP KUMAR | 1632 | §102§103§112 | Final Rejection | — | Pending | Aug 10, 2022 |
| 17794001 | PEPTIDE INHIBITORS OF GUANINE NUCLEOTIDE EXCHANGE FACTOR H-1 | KOMATSU, LI N | 1658 | §102 | Non-Final OA | — | Pending | Jul 20, 2022 |
| 17793221 | DRUG ELUTING BIOMATERIALS | PRAGANI, RAJAN | 1614 | §102§103§112 | Final Rejection | 12d | Pending | Jul 15, 2022 |
| 17784836 | TIME-RESOLVED METHOD OF PROTEIN ANALYSIS | GZYBOWSKI, MICHAEL STANLEY | 1798 | §103 | Non-Final OA | — | Pending | Jun 13, 2022 |
| 17783167 | GENE THERAPY COMPOSITION AND TREATMENT FOR MYH7-LINKED CARDIOMYOPATHY | MOLOYE, TITILAYO | 1632 | §112 | Final Rejection | 16d | Pending | Jun 07, 2022 |
| 17775172 | Extracellular Matrix Gels, and Organoid Cultures Comprising the Same | SCHUBERG, LAURA J | 1631 | §103 | Final Rejection | 31d overdue | Pending | May 06, 2022 |
| 17773103 | METHOD FOR THE PRODUCTION OF MÜLLER CELLS AND CELL PRODUCT | ZHU, JIANJIAN | 1631 | §103§112 | Non-Final OA | — | Pending | Apr 29, 2022 |
| 17641786 | Methods and Apparatuses for Fabricating Polymeric Conformal Coatings, Parts Coated With Polymeric Conformal Coatings, and Optical Apparatus Including Said Parts | BOWMAN, ANDREW J | 1717 | §103 | Non-Final OA | 1d overdue | Pending | Mar 09, 2022 |
| 17309348 | DIFFERENTIAL METHYLATION | BAUSCH, SARAE L | 1699 | §101§112 | Final Rejection | 22d | Pending | May 20, 2021 |
| 17044558 | DRAINAGE DEVICE AND METHODS | LEVY, BRANDON WILLIAM | 3781 | §103 | Non-Final OA | 27d | Pending | Oct 01, 2020 |
| 18299415 | METHOD OF TREATING CANCER WITH A BRCA1-ASSOCIATED PROTEIN 1 INHIBITOR AND A DEATH RECEPTOR LIGAND | DENT, ALANA HARRIS | 1643 | §103 | Final Rejection | — | Pending | Apr 12, 2023 |
| 17904393 | AGENTS FOR USE IN THE TREATMENT OF TISSUE DAMAGE 2 | WELLS, LAUREN QUINLAN | 1622 | §112DP | Non-Final OA | 87d overdue | Pending | Aug 17, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial